101 related articles for article (PubMed ID: 8312881)
1. Radioiodination of 2'-deoxyuridine: preparation and preliminary evaluation in tumour-bearing rats.
Goethals P; Lodewyckx W; van Eijkeren M; Dams R
Appl Radiat Isot; 1994 Feb; 45(2):149-53. PubMed ID: 8312881
[TBL] [Abstract][Full Text] [Related]
2. The preparation of clinical grade 5-[123I]iodo-2'-deoxyuridine and 5-[125I]iodo-2'-deoxyuridine with high in vitro stability and the potential for early proliferation scintigraphy.
Schaffland AO; Delaloye AB; Kosinski M; Dupertuis YM; Buchegger F
Nucl Med Commun; 2004 May; 25(5):461-8. PubMed ID: 15100504
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of (131/123)I-5-iodo-2'-deoxycytidine as a novel proliferation probe in a tumor mouse model.
Chang WY; Kuo WT; Wu CY; Lin CY; Chan PC; Shen CC; Liu RS; Wang HE; Chen CL
Appl Radiat Isot; 2013 Jul; 77():166-73. PubMed ID: 23602704
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 6-methyl[11C]-2'-deoxyuridine and evaluation of its in vivo distribution in Wistar rats.
Goethals P; Volders F; Van der Eycken J; van Eijkeren M; Lemahieu I; Dams R
Nucl Med Biol; 1997 Nov; 24(8):713-8. PubMed ID: 9428595
[TBL] [Abstract][Full Text] [Related]
5. Radioiodination of DNA and in vivo studies for tumor localization.
Ithakissios DS
Int J Nucl Med Biol; 1980; 7(1):17-24. PubMed ID: 7358462
[No Abstract] [Full Text] [Related]
6. Rationale of 5-(125)I-iodo-4'-thio-2'-deoxyuridine as a potential iodinated proliferation marker.
Toyohara J; Hayashi A; Sato M; Tanaka H; Haraguchi K; Yoshimura Y; Yonekura Y; Fujibayashi Y
J Nucl Med; 2002 Sep; 43(9):1218-26. PubMed ID: 12215562
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biodistribution of 3'-fluoro-5-[(131)I]iodo-2'-deoxyuridine: a comparative study of [(131)I]FLIdU and [(18)F]FLT.
Vogg AT; Buck AK; Schmid M; Neumaier B; Wczasek K; Zlatopolskiy BD; Reske SN
Nucl Med Biol; 2007 Apr; 34(3):273-81. PubMed ID: 17383577
[TBL] [Abstract][Full Text] [Related]
8. A rapid quantitative method for the preparation of 123I-iodo-hippuric acid.
Hawkins L; Elliott A; Shields R; Herman K; Horton P; Little W; Umbers C
Eur J Nucl Med; 1982; 7(2):58-61. PubMed ID: 7084269
[TBL] [Abstract][Full Text] [Related]
9. An improved method for rapid and efficient radioiodination of iodine-123-IQNB.
Lee KS; He XS; Jones DW; Coppola R; Gorey JG; Knable MB; deCosta BR; Rice KC; Weinberger DR
J Nucl Med; 1996 Dec; 37(12):2021-4. PubMed ID: 8970527
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the uptake of [123/125I]-2-iodo-D-tyrosine and [123/125I]-2-iodo-L-tyrosine in R1M rhabdomyosarcoma cells in vitro and in R1M tumor-bearing Wag/Rij rats in vivo.
Bauwens M; Lahoutte T; Kersemans K; Gallez C; Bossuyt A; Mertens J
Nucl Med Biol; 2006 Aug; 33(6):735-41. PubMed ID: 16934692
[TBL] [Abstract][Full Text] [Related]
11. 5-[123I/125I]iodo-2'-deoxyuridine in metastatic lung cancer: radiopharmaceutical formulation affects targeting.
Semnani ES; Wang K; Adelstein SJ; Kassis AI
J Nucl Med; 2005 May; 46(5):800-6. PubMed ID: 15872354
[TBL] [Abstract][Full Text] [Related]
12. Updating the procedure for metaiodobenzylguanidine labelling with iodine radioisotopes employed in industrial production.
Franceschini R; Mosca R; Bonino C
J Nucl Biol Med (1991); 1991; 35(4):183-5. PubMed ID: 1823814
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, radiolabeling, and biodistribution of putative metabolites of iodoazomycin arabinoside.
Lee HC; Kumar P; McEwan AJ; Wiebe LI; Mercer JR
Nucl Med Biol; 2000 Jan; 27(1):61-8. PubMed ID: 10755647
[TBL] [Abstract][Full Text] [Related]
14. Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts.
Reist CJ; Archer GE; Kurpad SN; Wikstrand CJ; Vaidyanathan G; Willingham MC; Moscatello DK; Wong AJ; Bigner DD; Zalutsky MR
Cancer Res; 1995 Oct; 55(19):4375-82. PubMed ID: 7671250
[TBL] [Abstract][Full Text] [Related]
15. Radioiodination of nicotine with specific activity high enough for mapping nicotinic acetylcholine receptors.
Kämpfer I; Sorger D; Schliebs R; Kärger W; Günther K; Schulze K; Knapp WH
Eur J Nucl Med; 1996 Feb; 23(2):157-62. PubMed ID: 8925850
[TBL] [Abstract][Full Text] [Related]
16. A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma.
Boschi A; Uccelli L; Duatti A; Colamussi P; Cittanti C; Filice A; Rose AH; Martindale AA; Claringbold PG; Kearney D; Galeotti R; Turner JH; Giganti M
Nucl Med Commun; 2004 Jul; 25(7):691-9. PubMed ID: 15208496
[TBL] [Abstract][Full Text] [Related]
17. Iodo-Gen-mediated radioiodination of nucleic acids.
Piatyszek MA; Jarmolowski A; Augustyniak J
Anal Biochem; 1988 Aug; 172(2):356-9. PubMed ID: 3189783
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of radioiodinated monoclonal antibodies in the rat. Influence of tumour growth and reticuloendothelial system host modulation.
Holmberg SB; Hafström L; Aronsson EF; Gretarsdottir J; Jacobsson L; Mattsson S; Lindholm L
Acta Oncol; 1989; 28(5):699-703. PubMed ID: 2590546
[TBL] [Abstract][Full Text] [Related]
19. The effect of dose loading and of double labelling with 57Co and 125I on the tissue distribution in animals.
Vos CM; Westera G; van der Jagt PJ; van Zanten B
Eur J Nucl Med; 1979 Oct; 4(5):393-6. PubMed ID: 93048
[TBL] [Abstract][Full Text] [Related]
20. Synkavit and its direct labelling with iodine-125, as a potential anti-cancer drug.
Unak T; Unak P
Nucl Med Biol; 1993 Oct; 20(7):889-94. PubMed ID: 8242002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
